NextGen® Ambulatory EHR 5.9 Earns 2015 Edition ONC Health IT Certification from Drummond Group LLC
November 14 2017 - 7:30AM
Business Wire
Quality Systems, Inc. (NASDAQ:QSII), known to its clients as
NextGen Healthcare, announced today the company’s electronic health
record – NextGen® Ambulatory EHR 5.9 – achieved Office of the
National Coordinator for Health Information Technology (ONC-HIT)
2015 Edition Health IT Module certification from the Drummond
Group, LLC, an authorized certification body (ACB).
This stamp of approval designates that NextGen Ambulatory EHR
5.9 is 2015 Edition certified electronic health record technology
(CEHRT) and offers the functionality for eligible providers and
hospitals to meet MIPS ACI and Meaningful Use Stage 3 requirements,
qualifying these organizations to receive payments under the
ongoing Quality Payment Program (QPP) and Meaningful Use (MU) EHR
Incentive Programs.
“Achieving 2015 Edition certification of our NextGen Ambulatory
EHR 5.9 is all about supporting our clients,” said Rusty Frantz,
president and CEO, NextGen Healthcare. “Meeting our original
commitments and deadlines for 2015 Edition certification means our
clients not only have flexibility in 2018 for QPP and MIPS
reporting – with both 2014 Edition and 2015 Edition CEHRT – but
they can earn bonus incentive payments recently announced by CMS
tied to exclusive use of 2015 Edition CEHRT.”
NextGen Healthcare clients and interested parties can review
NextGen Ambulatory EHR 5.9 2015 Edition CEHRT details at the
certified health IT product list here on the healthit.gov
website.
2015 Edition Disclosure Language
This Health IT Module – NextGen Ambulatory EHR 5.9 – is 2015
Edition compliant and has been certified by an ONC-ACB in
accordance with the applicable certification criteria adopted by
the Secretary of Health and Human Services. This certification does
not represent an endorsement by the U.S. Department of Health and
Human Services.
NextGen Ambulatory EHR 5.9 was created by NextGen Healthcare,
with headquarters located at 18111 Von Karman Avenue, Irvine, CA
92612. Website is www.nextgen.com. Information about NextGen
Ambulatory EHR 5.9 2015 Edition CEHRT is available from Robert
Larson, Director, Product Management – robertl@nextgen.com. NextGen
Ambulatory EHR 5.9 earned 2015 Edition Health IT module
certification on October 25, 2017. CHPL-ID
15.04.04.2054.Next.59.01.1.171025.
About Quality Systems, Inc.
Quality Systems, Inc., known to its clients as NextGen
Healthcare, provides a range of software, services, and analytic
solutions to medical and dental group practices. The Company’s
portfolio delivers foundational capabilities to empower physician
success, enrich the patient care experience and enable the
transition to value-based healthcare. Visit www.qsii.com and
www.nextgen.com for additional information.
About Drummond Group, LLC
Drummond Group LLC is a global software test and certification
lab that serves a wide range of vertical industries. In healthcare,
Drummond Group LLC tests and certifies Controlled Substance
Ordering Systems (CSOS), Electronic Prescription of Controlled
Substances (EPCS) software and processes, and Electronic Health
Records (EHRs) – designating the trusted test lab as the only
third-party certifier of all three initiatives designed to move the
industry toward a digital future. The company was founded in 1999
and is accredited for the Office of the National Coordinator Health
IT Certification Program as an Authorized Certification Body (ACB)
and an Authorized Test Lab (ATL). For more information, please
visit http://www.drummondgroup.com.
SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS
This news release may contain forward-looking statements within
the meaning of the federal securities laws, including but not
limited to, statements made by Rusty Frantz, President and
CEO, statements regarding certifications of the Company’s products,
and other statements regarding future events, developments in the
Company’s business and in the overall healthcare sector, the
Company's future performance, as well as management's expectations,
beliefs, intentions, plans, estimates or projections relating to
the future. The Company cautions investors not to place undue
reliance on any such forward-looking statements, which are based on
information available at the time those statements are made or
management's good faith belief as of that time with regard to
future events, and should not be read as a guarantee of future
performance or results. Risks and uncertainties exist that may
cause the results to differ materially from those set forth in
these forward-looking statements. Factors that could cause the
anticipated results to differ from those described in the
forward-looking statements and additional risks and uncertainties
are set forth in Part I, Item A of our most recent Annual Report on
Form 10-K and subsequently filed Quarterly Reports on Form 10-Q,
including but not limited to: the volume and timing of systems
sales and installations; length of sales cycles and the
installation process; the possibility that products will not
achieve or sustain market acceptance; seasonal patterns of sales
and customer buying behavior; impact of incentive payments under
The American Recovery and Reinvestment Act on sales and the ability
of the Company to meet continued certification requirements; the
development by competitors of new or superior technologies; the
timing, cost and success or failure of new product and service
introductions, development and product upgrade releases; undetected
errors or bugs in software; product liability; litigation and
government investigations; changing economic, political or
regulatory influences in the health-care industry; changes in
product-pricing policies; availability of third-party products and
components; competitive pressures including product offerings,
pricing and promotional activities; the Company's ability or
inability to attract and retain qualified personnel; possible
regulation of the Company's software by the U.S. Food and Drug
Administration; changes of accounting estimates and assumptions
used to prepare the prior periods' financial statements;
disruptions caused by acquisitions of companies, products, or
technologies; and general economic conditions. These
forward-looking statements speak only as of the date hereof. The
Company undertakes no obligation to publicly update any
forward-looking statements, whether as a result of new information,
future events or otherwise.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171114005876/en/
For Investor Relations Inquiries:Quality Systems,
Inc.Jamie Arnold, 949-255-2600Chief Financial
OfficerJArnold@nextgen.comorFor Media and Public Relations
Inquiries:Finn PartnersAgata Porter,
212-715-1595agata.porter@finnpartners.com
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quality Systems (NASDAQ:QSII)
Historical Stock Chart
From Apr 2023 to Apr 2024